Table II.
Characteristic | n (%) |
---|---|
mRNA analysis population | 57 (100) |
Gender | |
Male | 39 (68) |
Female | 18 (32) |
Age (years) | |
Median | 65 |
Range | 39–80 |
<65 | 25 (44) |
≥65 | 32 (56) |
UICC T | |
T1/2 | 2 (4) |
T3/4 | 55 (96) |
UICC N | |
N(−) | 15 (26) |
N(+) | 42 (74) |
UICC M | |
M(−) | 55 (96) |
M(+) | 2 (4) |
UICC stage | |
I–II | 55 (96) |
III–IV | 2 (4) |
Histology | |
Poor | 4 (7) |
Moderate | 44 (77) |
Well | 3 (5) |
Other | 6 (11) |
Adjuvant chemotherapy regimen | |
Gemcitabine | 42 (74) |
S-1 | 15 (26) |